Clinical Trial Update: Study of Oxaliplatin and Taxotere in Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating oxaliplatin in combination with docetaxel (Taxotere) for prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)
• Taxotere (docetaxel)

Snippet

Sponsor: University of Pittsburgh | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED